Phase 2 Study of Pembrolizumab and Chemotherapy in Patients With Newly Diagnosed Classical Hodgkin Lymphoma (KEYNOTE-C11)

  • Gilbertson, Michael (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date4/11/21 → 3/11/26

Keywords

  • phase 2 study
  • treatment efficacy
  • treatment safety